These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9021354)

  • 21. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
    Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
    Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
    Papaleo E; Doldi N; De Santis L; Marelli G; Marsiglio E; Rofena S; Ferrari A
    Hum Reprod; 2001 Nov; 16(11):2263-6. PubMed ID: 11679501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.
    Christin-Maitre S; Hugues JN;
    Hum Reprod; 2003 Aug; 18(8):1626-31. PubMed ID: 12871872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.
    Yong EL; Ng SC; Chan CL; Kumar J; Teo LS; Ratnam SS
    Gynecol Endocrinol; 1997 Feb; 11(1):35-42. PubMed ID: 9086338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.
    Turkmen S; Backstrom T; Idil M
    Gynecol Endocrinol; 2004 Aug; 19(2):69-78. PubMed ID: 15624268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is clomiphene citrate stair-step protocol a good alternative to gonadotrophins in clomiphene-resistant PCO patients? Prospective study.
    Salaheldin AbdelHamid AM; Rateb AM; Ismail Madkour WA
    J Obstet Gynaecol Res; 2016 May; 42(5):547-53. PubMed ID: 26786750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M; Sjöblom P; Pousette A; Hillensjö T
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Li Y; Gao Q; Sheng Y; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
    Neyro JL; Barrenetxea G; Montoya F; Rodriguez-Escudero FJ
    Hum Reprod; 1991 Feb; 6(2):218-21. PubMed ID: 1905311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
    Polson DW; Mason HD; Saldahna MB; Franks S
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
    Buckler HM; Critchley HO; Cantrill JA; Shalet SM; Anderson DC; Robertson WR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.
    van Santbrink EJ; Donderwinkel PF; van Dessel TJ; Fauser BC
    Hum Reprod; 1995 May; 10(5):1048-53. PubMed ID: 7657739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
    van der Meer M; de Boer JA; Hompes PG; Schoemaker J
    Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.